SCHEMBL18372005

SCHEMBL18372005

CCOC(=O)c1cccc(Cl)c1-c1ccc2oc3ccccc3c2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRP O00591 1/20 0.51
▸ GABRD O14764 1/20 0.51
▸ GABRA1 P14867 1/20 0.51
▸ GABRB1 P18505 1/20 0.51
▸ GABRG2 P18507 1/20 0.51
▸ GABRB3 P28472 1/20 0.51
▸ GABRA5 P31644 1/20 0.51
▸ GABRA3 P34903 1/20 0.51
▸ GABRA2 P47869 1/20 0.51
▸ GABRB2 P47870 1/20 0.51
▸ GABRA4 P48169 1/20 0.51
▸ GABRE P78334 1/20 0.51
▸ GABRA6 Q16445 1/20 0.51
▸ GABRG1 Q8N1C3 1/20 0.51
▸ GABRG3 Q99928 1/20 0.51
▸ GABRQ Q9UN88 1/20 0.51
▸ KDM4E B2RXH2 2/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ GAA P10253 2/20 0.50
▸ GLA P06280 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18356509 0.83 HSP90AA1 (0.45) KDM4EALDH1A1RAB9AAHRMAOB
SCHEMBL4262733 0.83 KDM4E (0.63) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL18372006 0.81 L3MBTL1 (0.41) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL18372551 0.81 ALOX5 (0.48) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7639368 0.78 TSHR (0.59) KDM4EALDH1A1GAARAB9ATSHR
SCHEMBL7644170 0.77 TSHR (0.53) KDM4EALDH1A1GAAL3MBTL1TSHR
SCHEMBL11914433 0.76 KDM4E (0.57) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL25744700 0.76 MAPT (0.53) KDM4EALDH1A1GAAGLARAB9A
SCHEMBL21096574 0.74 GABRP (0.64) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7642334 0.73 GAA (0.54) GABRA2GABRB2KDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170005274-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2017-01-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170005274-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC EQUIPMENT LEF1, RPL6, OR10J3 GABRP 4780/4885GABRD 4392/4885GABRA1 3028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback